Articles published by City Therapeutics

City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

October 19, 2026

From City Therapeutics

Via GlobeNewswire

City Therapeutics Announces Pricing of Upsized Initial Public Offering

October 15, 2026

From City Therapeutics

Via GlobeNewswire

City Therapeutics Appoints Keith Regnante, MBA, as Chief Financial Officer and Mary Beth DeLena, J.D., as Chief Legal Officer

August 11, 2026

From City Therapeutics

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.